先端分野の市場情報を提供する株式会社グローバルインフォメーション（神奈川県川崎市、代表取締役社長：小野 悟）は、2014年9月15日～16日 米国、アーリントンにて開催されますIBC Life Sciences主催 国際学会「Cell Therapy Bioprocessing 2014 - 細胞療法バイオ ...
先端分野の市場情報を提供する株式会社グローバルインフォメーション（神奈川県川崎市、代表取締役社長：小野 悟）は、2012年9月11～12日 米国、アーリントンにて開催されます、IBC Life Sciences主催 国際学会「Cell Therapy Bioprocessing 2012 （2012年 細胞療法バイオ ...
The "Cell Therapy Processing: Global Markets and Technologies" report has been added to ResearchAndMarkets.com's offering. The global market for cell therapy processing is estimated to grow from $2.7 ...
We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...
Lumacyte CEO on how real-time insight is driving down manufacturing failures and opening doors for more patients.
Breakthrough partnership with Universal Robots transforms "artisanal" manufacturing, making personalized, life-saving cancer treatments affordable and widely available. "This is a quantum leap in ...
Partnership aimed at improving cell separation and increasing cell viability WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (CRL) and Akadeum Life Sciences, a ...
Under the service agreement, BOOST Pharma has transferred its manufacturing process to RoslinCT’s state-of-the-art facilities in Edinburgh, Scotland. The partnership will progress toward GMP ...
Takeda discontinues cell therapy efforts, seeking external partnerships to leverage platform technologies and advance research programs. Focus shifts to near-term investments in small molecules, ...
Charles River Laboratories International, Inc. (NYSE: CRL) and Akadeum Life Sciences, a leader in advanced cell separation technologies, announced today the integration of Akadeum’s GMP-grade Human T ...
Clinical Trials Arena on MSN
FDA increases manufacturing flexibility for cell and gene therapies
Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する
フィードバック